VINC

Vincerx Pharma, Inc. Common Stock

Delisted

VINC was delisted on the 22nd of April, 2025.

56 hedge funds and large institutions have $249M invested in Vincerx Pharma, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
Holders Change %
0%
% of All Funds
0.98%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
9
Increased
26
Reduced
13
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Citigroup
51
Citigroup
New York
$24K +$20.5K +65 +591%
Legal & General Group
52
Legal & General Group
United Kingdom
$22K +$13.3K +41 +152%
AIP
53
Ameritas Investment Partners
Nebraska
$16K +$10.2K +32 +178%
TRCT
54
Tower Research Capital (TRC)
New York
$10K +$9.36K +29 +1,450%
TWA
55
TCI Wealth Advisors
Arizona
$1K +$1K +3 New
CAPTRUST Financial Advisors
56
CAPTRUST Financial Advisors
North Carolina
$1K +$1K +4 New
Bank of Montreal
57
Bank of Montreal
Ontario, Canada
-$3.18M -12,645 Closed
PI
58
Putnam Investments
Massachusetts
-$2.87M -11,052 Closed
JGC
59
J. Goldman & Co
New York
-$1.51M -5,808 Closed
Millennium Management
60
Millennium Management
New York
-$663K -2,552 Closed
Creative Planning
61
Creative Planning
Kansas
-$455K -1,750 Closed
M
62
Murchinson
Ontario, Canada
-$377K -1,452 Closed
JF
63
Jump Financial
Illinois
-$260K -1,000 Closed
SC
64
Shay Capital
New York
-$148K -568 Closed
PCM
65
Penserra Capital Management
California
-$43K -166 Closed